Price Alert

Magenta Therapeutics Inc. (MGTA)

NASDAQ: MGTA · Real-Time Price · USD

0.70

-0.06 (-7.69%)

At close: Sep 11, 2023, 10:00 PM

Magenta Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.12M	22.79M	33.67M	314.17M	157.28M	62.63M	48.52M	57.63M	59.03M	54.83M	71.77M	131.65M	157.54M	155.03M	49.29M
Short-Term Investments	253.11M	252.45M	247.45M	46.54M	32.59M	14.96M	29.68M	54.41M	69.26M	84.59M	84.84M	45.28M	35.08M	52.77M	83M
Long-Term Investments	68.31M	81.73M	61.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	7.63M	9.63M	4.74M	2.64M	116K	n/a	n/a	1.78M	1.78M	1.78M	1.78M	5.55M	1.78M	1.78M	1.78M
Receivables	1M	n/a	1.29M	835K	519K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	6.77M	5.66M	5.07M	4.14M	1.06M	1.04M	2.91M	3.56M	3.81M	2.62M	3.63M	3.77M	3.86M	2.38M	2.81M
Total Current Assets	271M	280.9M	287.49M	365.69M	191.45M	78.64M	83.44M	115.6M	132.1M	142.04M	160.24M	176.93M	196.47M	210.19M	135.1M
Property-Plant & Equipment	1.64M	1.75M	541K	631K	893K	n/a	n/a	29.26M	30.25M	31.3M	32.37M	7.46M	7.98M	8.41M	7.74M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	77.58M	93.1M	66.76M	3.27M	1.01M	n/a	n/a	31.04M	32.03M	33.08M	34.15M	13.01M	9.76M	10.19M	9.52M
Total Assets	348.58M	374.01M	354.25M	368.96M	192.46M	78.64M	83.44M	146.65M	164.12M	175.12M	194.38M	189.93M	206.24M	220.38M	144.62M
Account Payables	8.27M	4.58M	7.57M	3.69M	1.37M	813K	1.08M	2.45M	2.58M	2.05M	4.44M	3.04M	1.89M	2.93M	2.11M
Deferred Revenue	479K	479K	100K	100K	100K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	226K	320K	311K	377K	413K	n/a	n/a	3.82M	3.62M	3.42M	3.25M	n/a	n/a	n/a	n/a
Other Current Liabilities	7.98M	13.07M	7.73M	5.86M	11.2M	3.22M	4.9M	8.27M	6.72M	5.79M	6.41M	7.82M	8.26M	8.15M	7.09M
Total Current Liabilities	16.95M	18.45M	15.71M	10.03M	13.08M	4.03M	5.98M	14.55M	12.92M	11.26M	14.09M	10.86M	10.15M	11.08M	9.21M
Long-Term Debt	1.17M	1.17M	n/a	30K	257K	n/a	n/a	26.14M	27.18M	28.19M	29.1M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.85M	1.91M	640K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.02M	3.08M	640K	712K	1M	n/a	1.08M	26.14M	27.18M	28.19M	29.1M	6.4M	6.4M	6.4M	6.36M
Total Liabilities	19.97M	21.53M	16.35M	10.74M	14.08M	4.03M	5.98M	40.69M	40.1M	39.44M	43.2M	17.26M	16.55M	17.49M	15.56M
Total Debt	1.4M	1.49M	311K	407K	670K	n/a	n/a	29.96M	30.8M	31.61M	32.35M	n/a	n/a	n/a	n/a
Common Stock	32K	31K	29K	29K	15K	61K	61K	61K	61K	59K	59K	59K	59K	59K	49K
Retained Earnings	-203.9M	-174.39M	-145.95M	-120.78M	-78.86M	-434.48M	-431.2M	-402.03M	-381.85M	-365.79M	-348.52M	-325.57M	-306.27M	-288.85M	-271.92M
Comprehensive Income	270K	106K	681K	-37K	-4K	-3K	-16K	-181K	-462K	-602K	-469K	-30K	1K	2K	9K
Shareholders Equity	328.61M	352.48M	337.9M	358.22M	178.38M	74.6M	77.46M	105.96M	124.03M	135.68M	151.19M	172.67M	189.69M	202.89M	129.06M
Total Investments	321.42M	334.18M	308.93M	n/a	32.59M	14.96M	29.68M	54.41M	69.26M	84.59M	84.84M	45.28M	35.08M	52.77M	83M